阿尔茨海默病的血浆生物标志物：Aβ1-42/1-40与AβX-42/X-40的对比 - Suppr

Blood plasma biomarkers for Alzheimer's disease: Aβ1-42/1-40 vs. AβX-42/X-40.

作者信息

Klafki Hans-Wolfgang, Wirths Oliver, Jahn Olaf, Morgado Barbara, Esselmann Hermann, Wiltfang Jens

机构信息

Department of Psychiatry and Psychotherapy, University Medical Center, Goettingen, Georg-August-University, Goettingen, Germany.

出版信息

Clin Chem Lab Med. 2023 Oct 2;62(2):e56-e57. doi: 10.1515/cclm-2023-0990. Print 2024 Jan 26.

DOI:10.1515/cclm-2023-0990

PMID:37775501

Abstract

摘要

相似文献

Blood plasma biomarkers for Alzheimer's disease: Aβ1-42/1-40 vs. AβX-42/X-40.

Clin Chem Lab Med. 2023 Oct 2;62(2):e56-e57. doi: 10.1515/cclm-2023-0990. Print 2024 Jan 26.

Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.

Alzheimers Res Ther. 2018 Mar 20;10(1):32. doi: 10.1186/s13195-018-0361-3.

Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?

Fluids Barriers CNS. 2022 Dec 3;19(1):96. doi: 10.1186/s12987-022-00390-4.

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.

J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

Associations between plasma complement C1q and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.

J Alzheimers Dis. 2025 Apr;104(4):1136-1146. doi: 10.1177/13872877251322808. Epub 2025 Mar 26.

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.

Alzheimers Dement. 2014 Nov;10(6):808-17. doi: 10.1016/j.jalz.2014.03.003. Epub 2014 Aug 20.

Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer's Disease.

J Alzheimers Dis. 2024;97(1):447-458. doi: 10.3233/JAD-230744.

Plasma p-tau217 and p-tau217/Aβ1-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: Insights for research and clinical practice.

Alzheimers Dement. 2025 Feb;21(2):e14536. doi: 10.1002/alz.14536. Epub 2025 Jan 30.

Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.

J Alzheimers Dis. 2021;81(1):263-272. doi: 10.3233/JAD-201426.

A data-driven model of biomarker changes in sporadic Alzheimer's disease.

Brain. 2014 Sep;137(Pt 9):2564-77. doi: 10.1093/brain/awu176. Epub 2014 Jul 9.

本文引用的文献

CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa assays targeting distinct amyloid regions.

Clin Chem Lab Med. 2023 Sep 4;62(2):332-340. doi: 10.1515/cclm-2023-0659. Print 2024 Jan 26.

Is plasma amyloid-β 1-42/1-40 a better biomarker for Alzheimer's disease than AβX-42/X-40?

Fluids Barriers CNS. 2022 Dec 3;19(1):96. doi: 10.1186/s12987-022-00390-4.

Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.

Alzheimers Dement (Amst). 2021 Feb 6;13(1):e12131. doi: 10.1002/dad2.12131. eCollection 2021.

Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.

Alzheimers Dement. 2017 Aug;13(8):841-849. doi: 10.1016/j.jalz.2017.06.2266. Epub 2017 Jul 19.

Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.

Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):208-225. doi: 10.1016/j.bbadis.2017.07.005. Epub 2017 Jul 13.

Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein.

Front Aging Neurosci. 2016 Sep 27;8:223. doi: 10.3389/fnagi.2016.00223. eCollection 2016.

Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Proc Jpn Acad Ser B Phys Biol Sci. 2014;90(3):104-17. doi: 10.2183/pjab.90.104.

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.

Alzheimers Dement. 2009 Jan;5(1):18-29. doi: 10.1016/j.jalz.2008.10.004.

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.

J Proteome Res. 2007 Nov;6(11):4433-9. doi: 10.1021/pr0703627. Epub 2007 Oct 10.

Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species.

Proteomics. 2007 Oct;7(20):3815-20. doi: 10.1002/pmic.200700311.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Blood plasma biomarkers for Alzheimer's disease: Aβ1-42/1-40 vs. AβX-42/X-40.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献